Wednesday, July 8, 2026

pharma · Parkinson Disease · Tuberculosis · GANX

Gain Therapeutics

Gain Therapeutics trial registry — 4 ClinicalTrials.gov studies with program phase, status, and indication context.

Bethesda, USA HQ
2017 Founded
28 Employees
Public company Type
GANX · NYSE Ticker
Company details
Status
Public
HQ
Bethesda, USA
Founded
2017
Employees
28
Programs
4
Drugs
7
Patents
27
Intelligence · Clinical Trials

Gain Therapeutics clinical trials

Registry index of 4 ClinicalTrials.gov studies linked to Gain Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.

Gain Therapeutics trial registry — 4 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

4 updates

Latest clinical program signals indexed for Gain Therapeutics.

  1. combined fixed dose combination — Approved

    Clinical update
  2. Low Dose GT-02287 — Phase 2

    Clinical update
  3. Envita Stories Methodology in Long-term care Centres for old adults — Unknown

    Clinical update
  4. GT-02287 — Phase 1

    Clinical update

Trial registry

4 studies